Abstract: Pharmaceutical solution aerosol formulations comprising beclomethasone 17,21 dipropionate, ethanol, and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, and a mixture thereof.

Abstract: Compositions and methods for the treatment of mammalian skin lesions are provided. The compositions contain a protic acid and a chlorite ion, and may be applied topically to a lesion to promote healing. The compositions and methods are particularly useful in the dairy industry for the treatment of bovine hairy heel warts.

Abstract: The invention is a carotenoid agent for inhibiting the conversion of epithelial cells to tumours, the agent including an effective amount of a water insoluble carotenoid component in a suitable non-toxic carrier medium.

Abstract: An insecticidally-active water-in oil-out emulsion of limited stability is disclosed. The emulsion contains at least water, a hydrocarbon solvent, an insecticidally active material, and a surfactant. When this emulsion is sprayed onto a target surface, an aqueous phase separates from an oil phase in the air or shortly after hitting a target surface.

Abstract: The present invention discloses sustained release dental compositions, such as tooth bleaching or fluoride-containing compositions, having high viscosity and stickiness for treating tooth surfaces. For maximum results, an improved dental tray having reservoirs for holding the dental composition adjacent to the tooth surfaces being treated is preferably used in conjunction with the sustained release dental compositions. The sustained release dental compositions include carboxypolymethylene in a concentration in a range from about 3.5% to about 12% by weight of the dental composition, as well as a base so that the pH of the dental composition is in a range from about 5 to about 7, which results in a very high viscosity composition. The carboxypolymethylene also inhibits dilution of the dental compositions by saliva so that the compositions stay within the tray reservoirs over time, thereby providing sustained release, or prolonged delivery, of the active dental agent.

Abstract: Therapeutic compositions comprising a therapeutically effective amount of platelet derived growth factor in a hydroxyethyl cellulose gel are provided. These compositions may include a preservative, such as methyl paraben. These compositions may also include ethanol.

Abstract: A simulated capsule-like medicament comprising a subcoating of a mixture of a water-soluble, film-forming polymer, e.g. hydroxypropylmethyl cellulose and a hydrophobic plasticizer, e.g. castor oil, which promotes a smooth uniform and substantially bubble free outer coating, e.g. gelatin, for the capsule-like medicament; capsule-like medicaments which are slightly bowed in shape; and a process of making such medicaments.

Abstract: There is disclosed according to the present invention a method for the control of autonomic nerve function in a mammal comprising administering a therapeutically effective amount of botulinum toxin to the mammal. Preferred embodiments include administering the toxin to control the function of an autonomic nerve which contributes to at least one symptom of rhinorrhea, otitis media, excessive salivation, asthma, COPD, excessive stomach acid secretion, spastic colitis or excessive sweating.

Abstract: An innovative-type hair spray concentrate of defined Brookfield viscosity and solids content which is capable of delivering reduced VOC spray particles of acceptable quality under the Innovative Product Clause Regulations in combination with a suitable restricter valve and actuator system. The concentrate includes a fixative which is the half-ester of a copolymer of maleic anhydride and methyl vinyl ether having a weight average molecular weight of about 40,000 to about 70,000, which provides advantageous physical and use performance properties.

Abstract: The present invention discloses high viscosity sustained release dental compositions, such as tooth bleaching or fluoride compositions, for treating tooth surfaces. For maximum results, an improved dental tray having reservoirs for holding the dental composition adjacent the desired tooth surfaces is preferably used in combination with the sustained release dental composition. The sustained release dental compositions include a high carboxypolymethylene concentration which results in very high viscosity. The high level of carboxypolymethylene makes dilution of the dental compositions from saliva difficult and time consuming so that the compositions stay within the tray reservoirs, thereby providing sustained release. The concentrated carboxypolymethylene adds a unique tackiness to the dental composition which helps retain and seal the soft tray material against the patient's teeth.

Abstract: The present invention discloses high viscosity sustained release dental compositions, such as tooth bleaching or fluoride compositions, for treating tooth surfaces. For maximum results, an improved dental tray having reservoirs for holding the dental composition adjacent the desired tooth surfaces is preferably used in combination with the sustained release dental composition. The sustained release dental compositions include a high carboxypolymethylene concentration which results in very high viscosity. The high level of carboxypolymethylene makes dilution of the dental compositions from saliva difficult and time consuming so that the compositions stay within the tray reservoirs, thereby providing sustained release. The concentrated carboxypolymethylene adds a unique tackiness to the dental composition which helps retain and seal the soft tray material against the patient's teeth.

Abstract: A light-reflecting and/or transmitting element for a motor vehicle light is provided. The light-reflecting or transmitting element is coated with a surface coating which includes a non-water soluble binder, selected from the group consisting of polyacrylic resins, polyester resins and mixtures thereof, which binder is internally cross-linked by methylol groups or externally cross-linked by amino resins, and from about 5% to about 60% by weight of at least one nonionic wetting agent.

Abstract: Described is a metering spray designed for pernasal application, the spray containing at least one sex hormone or at least one metabolic precursor of a sex hormone or at least one derivative of a sex hormone or combinations of these, excepting the precursors of testosterone, or at least one biogenic amine, with the exception of catecholamines.

Abstract: Active ingredient containing liquid formulations wherein the active ingredient is made water and oil resistant after application thereof to a substrate by the addition to the formulation of a fluorinated acrylic copolymer. The substrate can be either an animate or inanimate object. Active ingredients include repellents, attractants, pesticides, growth regulators, sunscreen agents, or medicines. The liquid formulations can be aqueous or organic solvent based or a mixture thereof.

Abstract: An apparatus for use in respiratory therapy procedures in the field of medicine. The apparatus of the invention converts liquid medication into an aerosol mist comprising sub-micron size particles and provides for delivery of this mist with such high efficiency that up to 40% of the original dose of medication placed in the nebulizer will be deposited in the patient's lungs.

Abstract: The invention relates to new hydrocarbon compounds containing a fluorinated chain of formula I ##STR1## and to their process of preparation. The invention also relates to the use of these new compounds as thickening agents, in particular for non-aqueous media, such as cosmetic compositions, and to the cosmetic compositions containing them.

Abstract: Biological materials are joined, repaired or fused by heating the material in proximity to a mechanical support. Preferably, the mechanical support comprises a patch or bridge structure. In the most preferred embodiment, the patch is formed from collagen having a thickness from between 2 to 30 mils, and most preferably from 2 to 15 mils thick. Preferably, the patch or support structure contains holes or interlock vias which permit the coagulum to form a mechanical bond therewith, whether preformed or generated by an electrical energy source during welding. The preferred method comprises the steps of: first, placing the patch in contact with the materials to be joined, supplying energy to the tissue in an amount sufficient to form a coagulum at the surface of the patch, and finally, permitting the coagulum to form a mechanical bond with the support or patch.

Abstract: There is disclosed an aerosol comprising droplets of an aqueous dispersion of nanoparticles, said nanoparticles comprising insoluble beclomethazone particles having a surface modifier on the surface thereof. There is also disclosed a method for making the aerosol and methods for treatment using the aerosol.

Abstract: Disclosed herein is a method for the preparation of sodium chloride formulations having a substantially uniform particle size suitable to ensure the dispersible properties for inhalation into the lungs of a subject. The formulations thus prepared are also the subject of this disclosure. The method involves jet milling coarse sodium chloride in one or preferably two or more procedures using air pressure suitable to produce particles having a significant fraction that are less than about 7 microns in size. Immediately following the milling, the particles are vacuum dried in an oven using a temperature and time suitable to cure the product to prevent substantial aggregation over time.

Abstract: The invention relates to an oil-in-water emulsion and related method for administration of a drug to a mucosal surface. The emulsion has an aqueous continuous phase and a plurality of submicron particles having an average particle diameter of from 10 nm to 600 nm, with the particles having a hydrophobic core of a fat or oil which is surrounded by a surfactant layer. The emulsion further includes a drug and a mucoadhesive polymer which is a polymer or copolymer of acrylic acid or methacrylic acid, a poly(methyl vinyl ether/maleic anhydride) copolymer, pectin, alginic acid, hyaluronic acid, chitosan, gum tragacanth, karaya gum or carboxymethylcellulose. The hydrophobic core has less than 1% (w/w) protein, relative to the weight of the hydrophobic core, and the emulsion contains less than 5% (w/w) surfactant, relative to the weight of the hydrophobic core.